openPR Logo
Press release

In-Depth Analysis of the Peptide Synthesis Market: Growth Opportunities, Key Trends, and Forecast 2025-2034

03-18-2025 07:41 AM CET | Health & Medicine

Press release from: The Business Research Company

Peptide Synthesis Market Size

Peptide Synthesis Market Size

How Are the key drivers contributing to the expansion of the peptide synthesis market?
The surge in chronic diseases is anticipated to be a significant contributing factor to the expansion of the peptide synthesis market. Chronic diseases are long-standing health issues or non-communicable diseases (NCDs) that usually develop over time and tend to progress slowly. Peptide synthesis is beneficial for managing chronic diseases because peptides exhibit anti-inflammatory and antioxidant properties, which can help prevent ailments like cardiovascular diseases. Furthermore, peptides can target specific cellular processes and signaling pathways, providing new treatment and management solutions. As per the Australian Institute of Health and Welfare, a governmental body in Australia, the age-standardised death rate due to chronic conditions rose to 490 per 100,000 population in 2022 from 459 per 100,000 in 2021. Hence, the escalating prevalence of chronic diseases is chiefly responsible for driving the peptide synthesis market's growth. Role of Increased Healthcare Spending in the Growth of Peptide Synthesis Market

Get Your Peptide Synthesis Market Report Here:
https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

What growth opportunities are expected to drive the peptide synthesis market's CAGR through 2034?
The market size for peptide synthesis has witnessed considerable growth in the past few years. It is set to expand from $5.69 billion in 2024 to $6.19 billion in 2025, representing a compound annual growth rate (CAGR) of 8.8%. This significant growth during the previous years is due to the surge in peptide-oriented vaccines, advancements in biotechnology and biopharmaceuticals, an increased requirement for high-quality peptides, and the influence of regulatory approvals and standardization.

The market for peptide synthesis is anticipated to witness significant expansion in the forthcoming years. The market size is set to escalate to $8.9 billion by 2029, with a 9.5% compound annual growth rate (CAGR). Factors such as the rapid expansion of therapeutic peptides, surging demand for bespoke peptides, an augmented role in drug research and development, and the focus on peptide library for screening are contributors to the projected growth in the forecast period. Noteworthy trends during this period encompass the evolution of peptide mimetics, the uptake of novel amino acid derivatives, techniques for peptide cyclization, breakthroughs in solid-phase peptide synthesis (SPPs), and the implementation of click chemistry.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp

What are the emerging trends shaping the future of the peptide synthesis market?
Prominent corporations in the peptide synthesis market are working towards gaining a competitive advantage by introducing state-of-the-art peptide synthesizers like PurePep Sonata+. Compared to conventional peptide synthesizers, PurePep Sonata+ delivers enhanced efficiency, speed, and precision. For instance, Gyros Protein Technologies, a peptide synthesis and bioanalytical technology firm based in the US, launched PurePep Sonata+ peptide synthesizer in March 2022. The PurePep Sonata+ improves on the capabilities of Sonata XT by integrating real-time flow technology, a ground-breaking method which allows continuous observation of fluid flow rates within the system and offers a non-invasive process to ensure precise and accurate fluid transfers for a wide variety of viscosities.

Which growth-oriented segments of the peptide synthesis market are leading the industry's development?
The peptide synthesis market covered in this report is segmented -

1) By Product And Service: Reagents, Equipment, Services
2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes

Subsegments:
1) By Reagents: Amino Acids, Coupling Reagents, Protecting Groups, Cleavage Reagents
2) By Equipment: Peptide Synthesizers, Chromatography Systems, Mass Spectrometers, Other Analytical Instruments
3) By Services: Custom Peptide Synthesis, Peptide Characterization And Analysis, Peptide Modification Services, Consulting And Support Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13295

What regions are leading the charge in the peptide synthesis market?
North America was the largest region in the peptide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What companies are at the forefront of innovation in the peptide synthesis market?
Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd., MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13295&type=smp

What Is Covered In The Peptide Synthesis Global Market Report?

•Market Size Forecast: Examine the peptide synthesis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the peptide synthesis market for a structured understanding.
•Key Players Overview: Analyze major players in the peptide synthesis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the peptide synthesis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the peptide synthesis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the peptide synthesis market.
•Industry Challenges: Identify potential risks and obstacles affecting the peptide synthesis market.
•Competitive Landscape: Review strategic developments in the peptide synthesis market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-Depth Analysis of the Peptide Synthesis Market: Growth Opportunities, Key Trends, and Forecast 2025-2034 here

News-ID: 3920688 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Peptide

ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support. ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established